Unlocking New Horizons: Preparing for the CLDN18.2-Targeting ADCs in Advanced Gastric/GEJ Cancer

0:00-22:18

Please visit answersincme.com/CJF860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Manuel Rodriguez-Justo, MBBCh, MSc, MD, FRCPath; and Elizabeth Smyth, MD, FRCP. In this activity, experts in oncology and pathology discuss the impact of claudin 18.2 (CLDN18.2) tests and treatments for patients with advanced gastric or gastroesophageal junction cancers. Upon completion of this activity, participants should be better able to: Describe the rationale for CLDN18.2 testing in patients with advanced gastric and gastroesophageal junction cancers (GC/GEJC); Review the potential clinical impact of emerging CLDN18.2-targeted antibody-drug conjugates (ADCs) for...

Publisher

CME in Minutes: Education in Oncology & Hematology

Link

answersincme.com/CJF860

Published

October 9, 2026

Duration

22 min

Format

Podcast

Category

Lifestyle · Medicine

Source

RSS feed

Host

Answers in CME

CI

CME in Minutes: Education in Oncology & Hematology

@cmeinminuteseducationinoncol

#targetingadcs #advancedgastric #gejcancer #lifesciences #medicine

The Nile